burn here is the latest update on the federal court

New Post Public Reply Private Reply Replies (1) Message Board
john1234 BURN.NOTICE88 #5158
burn here is the latest update on the federal court hearings for the rescheduling of marijuana from a schedule 1 to a schedule 2 drug.

War on pot defies science, doctors testify in federal court

Posted on October 28, 2014 at 8:54 am by David Downs

Three medical experts testified in federal court in California Friday and Monday that modern science renders the war on marijuana unconstitutional. Decades of medical research show the drug is not the danger the government has made it out to be, they told a federal judge.

It’s a dramatic, landmark cultivation trial in the Eastern District of California with national implications. U.S. District Court Judge Kimberly J. Mueller is allowing a hearing on a defense motion to declare unconstitutional the continued classification of marijuana in Schedule I.

Defense witnesses Gregory Carter, MD, and Carl Hart, PhD testified in Sacramento in the case of U.S. v. Schweder, saying cannabis is one of mankind’s oldest, safest therapeutic substances. The federal classification of it as both “very dangerous” and “lacking medical use” is untenable. A second doctor, Philip Denny, MD, testified Monday and Tuesday.

Government witness Bertha Madras — PhD, and former deputy Drug Czar under President George W. Bush — argued in briefs that cannabis fails to measure up as a medicine. She equates the drug to heroin, in that humans no longer smoke poppies for pain relief.

But they are not equal. About 22,114, Americans will die from prescription drug overdoses this year, and heroin-mimicking opioid drugs kill more Americans than any other prescription drug. Cannabis has no lethal overdose level, and zero recorded deaths from overdose in human history.

San Francisco attorney Zenia Gilg and Heather Burke, both members of the NORML Legal Committee, argue in Schweder that the U.S. can’t both ignore Colorado and Washington legalization, and maintain pot is a schedule 1 drug — as dangerous as heroin, LSD and methamphetamine.

“ …the action taken by the Department of Justice is either irrational, or more likely proves the assertions made in Part I (B) of this Brief: marijuana does not fit the criteria of a Schedule I Controlled Substance.”

President Richard Nixon placed cannabis, dubbed “marijuana”, in the schedule 1 of drugs in 1971, overriding the recommendations of his hand-picked Shafer Commission, which recommended de-scheduling it. It’s remained there ever since. Americans consume 2,500-5,000 metric tons of cannabis per year.

Federal prosecutors filed the original indictment against 16 defendants in October 2011, in a case involving growing 1,884 plants in Shasta-Trinity National Forest. The U.S. seeks 10-15 years for six defendants in the case.

Pot law reform advocates called the hearing evidence of a “sea change” in the country over cannabis. “This is pretty unprecedented, at least in the contemporary era — having such an evidentiary process,” said Kris Hermes for Americans for Safe Access.

Last year the DEA again denied a petition to reschedule pot, but the federal government is encountering unprecedented pushback in its assertions cannabis has no medical value. The government already patented marijuana. One in 20 California adults are estimated to have used medical cannabis to treat a serious illness, and 92 percent of them thought it helped.Twenty-three states and Washington D.C. have medical marijuana laws.

“It’s amazing to have the opportunity of several expert witnesses to testify why they think marijuana is mis-scheduled — that’s historic,” Hermes said.

Either marijuana is as dangerous as heroin and prosecutors should shut down Colorado and Washington’s recreational markets, or it’s not and the classification is wrong.

“The schizophrenic stance is untenable. They continue to speak out of both sides of their mouth,” Hermes said.

This fall, Attorney General Eric Holder said Congress should revisit marijuana’s schedule 1 classification in light of modern science.

Don Duncan, organizer with ASA attended the hearings Monday and said they were entertaining.
“[Dr. Hart] was very good. He was very eloquent. The prosecutor was on his game. It was a good tennis match.”

Hearings are scheduled to continue today.

reference source
http://blog.sfgate.com/smellthetruth/2014/10/...ral-court/

Rightsmile Inc. (RIGH) Stock Research Links

RIGH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epson Unveils Early Black Friday Tech Deals

Updated Category News Views 79

Diving Headfirst into Holiday Tech Splurging The holiday hustle is upon us, folks, and Epson's stepping up with early Black Friday deals that'll have tech heads scrambling. They’re cutting prices up to $250 on their swanky home lineup—projectors, printers, scanners, you name it. This ain't just about making someone else smile, though; it's about the sweet spot where...

Continue Reading
Oxford Computer Group: A Microsoft Awards Finalist Again

Updated Category News Views 41

Oxford Computer Group Strikes Again Another day, another nod from the big boys at Microsoft, eh? Oxford Computer Group, now part of MajorKey Technologies, hasn't just found themselves in the mix—they're standing tall as a finalist for not one but two significant categories in the 2026 Microsoft Partner of the Year Awards: Secure Access and Defense and Intelligence. You...

Continue Reading
Nanjing Revives Cultural Legacy of Yangtze River

Updated Category News Views 18

Breathing Life into an Ancient Waterway You'd think the Yangtze River story's as old as the hills—well, you're not wrong. But today, there's a fresh wind blowing down its waters. On November 10, scholars, cultural buffs, and a mixed bag of experts moseyed into Nanjing. They weren't just there to nibble dumplings and wax poetic; they were fixing to shed new light on the...

Continue Reading
Decoding Lovense's Black Friday Deals for Savvy Shoppers

Updated Category News Views 24

The Smart Shopper's Guide to Black Friday Tech Black Friday ain't just a race for the cheapest jeans or a half-price TV anymore—now we're talking about smart tech that matters, like Lovense's offerings. Imagine shelling out for something that'll last and deliver genuine satisfaction instead of another closet filler. Yeah, I'm looking at you, cheap gadgets that croak in...

Continue Reading
NCPDP CEO Lee Ann Stember Retires After 46-Year Legacy

Updated Category News Views 28

A Remarkable Milestone in Healthcare Leadership It's not every day someone hangs up their boots after 46 years of relentlessly steering the ship, especially in the tumultuous seas of healthcare. Come June 1, 2027, Lee Ann Stember plans to do just that as she retires as President & CEO of the National Council for Prescription Drug Programs (NCPDP). Her tenure is marked by...

Continue Reading
Immunofoco’s Lentiviral Strategy for Cancer Control

Updated Category News Views 25

Revolutionizing Cancer Treatment: Immunofoco's Approach In the battle against B-cell malignancies, the old ways of doing things sometimes just don’t cut it, folks. Enter Immunofoco. At the recent Society for Immunotherapy of Cancer (SITC) 2026 meeting, they laid some ambitious cards on the table with their in vivo T-cell engager (TCE) delivery strategy. Engineering...

Continue Reading
Group 1 Automotive Expands with Lexus Gwinnett Acquisition

Updated Category News Views 79

Unifying the Landscape: Group 1's Bold Move with Lexus Gwinnett Another piece of the puzzle drops into place as Group 1 Automotive continues its aggressive campaign to unify its dealership network. The latest acquisition sees the Hennessy Lexus of Gwinnett rebranded as Lexus Gwinnett, adding another notch to their belt in the bustling Atlanta-market corridor. Group 1's...

Continue Reading
Capline Speeds Credentialing: AI Cuts 60% Off Wait Time

Updated Category News Views 41

AI and Dental Credentialing: A Game Changer? Is it just me, or is this push to AI-driven workflows becoming the latest buzz in every industry? Now, Capline Dental Services out of Houston says they've cracked the code on dental credentialing and, boy, is it something. By introducing AI into the mix, they've reportedly slashed credentialing time by 60%. You know what that...

Continue Reading
CAE Boosts Fiscal 2027 Outlook; Transformation On Track

Updated Category News Views 59

Revenue's down by a hair, but it's not as bleak as it seems. CAE Inc. (NASDAQ:CAE) just put its cards on the table for Q2 of fiscal 2027, and there's a mixed bag for us investors to chew over. Revenue dipped 2.6% year-over-year to $1,204.7 million. But hey, their adjusted EPS has climbed up to $0.33, a step up from $0.28 last year, which is a good sign of something right...

Continue Reading
Kava Meets Comics: A New Spot in King of Prussia

Updated Category News Views 73

A Social Revolution in King of Prussia Look, this ain't your typical bar review. We're talking about the Uncanny Comics and Kava Bar at King of Prussia Mall—where comic books, collectible treasures, and good company collide with a South Pacific vibe. Kava: Beyond Just Another Drink First off, if you're scratching your head about kava, don't fret. It's a beverage made...

Continue Reading

Top 5 Most Recently Viewed Articles

First Guaranty Bancshares Unveils Strong Q3 Financial Performance

Updated Category News Views 70

First Guaranty Bancshares, Inc. Financial Overview First Guaranty Bancshares, Inc. (NASDAQ: FGBI), headquartered in Louisiana, recently disclosed its financial results for the third quarter and nine months ending September 30, 2024. This report embodies the bank's continued growth and robust performance in the financial sector. Key Financial Highlights The highlights...

Continue Reading
Helius Medical Technologies Showcases PoNS Therapy Study Results

Updated Category News Views 199

Exciting Developments in Gait Therapy for MS Patients Helius Medical Technologies, Inc. (NASDAQ: HSDT), a pioneering neurotech company, is thrilled to unveil important findings concerning its Portable Neuromodulation Stimulator (PoNS). This innovative device addresses balance and gait challenges faced by those with multiple sclerosis (MS). The revelations will be...

Continue Reading
Iceland Seafood Reports Impressive Financial Growth Amid Challenges

Updated Category News Views 123

Impressive Financial Results from Iceland Seafood International Iceland Seafood International hf has reported strong financial performance in the first half of the year, showcasing a significant increase in profitability. The company has demonstrated resilience amidst market challenges, making strides in operational excellence and strategic growth initiatives. Outstanding...

Continue Reading
Amazon's Q3 2025 Earnings Highlights: Strong Revenue and Innovations

Updated Category News Views 431

Amazon's Third Quarter 2025 Financial Results Amazon.com, Inc. (NASDAQ: AMZN) has reported its third-quarter earnings indicating significant financial health and robust growth across sectors. The company announced an impressive revenue of $180.2 billion for the quarter, marking a 12% increase year-over-year when excluding foreign exchange impacts. This upward trend is...

Continue Reading
Sunshine Silver Mines Achieves Record Stock Growth with GATO

Updated Category News Views 136

GATO Stock Hits New Highs In a striking demonstration of market movement, GATO, the stock linked to Sunshine Silver Mines and Refining, has reached a new milestone, soaring to a 52-week high of $15.96. This remarkable climb comes in the context of a significant rally in precious metals, especially as silver becomes more prominent. Investor confidence in the company has...

Continue Reading